Licensing

Nature of Patent Licensing

A patent license is an authority given by the patent owner to another person to make, use, sell, offer for sale, or import the patented product, or to use the patented process and deal in products obtained directly from that process. It is not a transfer of ownership unless the parties clearly execute an assignment of the patent or of an undivided share in it.

The license operates as a waiver of the patent owner's right to exclude the licensee within the agreed scope. Acts outside the licensed field, territory, duration, quantity, or purpose remain unauthorized and may give rise to infringement as well as breach of contract.

Licensing is a commercial use of the patent system. It allows the patent owner to monetize exclusivity, allows the licensee to commercialize technology without owning the patent, and allows the public to receive the benefit of actual working, competition, access, and technology diffusion.

A patent license may cover the patented invention alone, or may be bundled with know-how, technical assistance, manufacturing data, quality-control standards, trademarks, regulatory support, or supply commitments. When the agreement transfers systematic knowledge for the manufacture of a product, application of a process, or rendering of a service, it is treated as a technology transfer arrangement and is subject to the special controls on voluntary licensing.

Voluntary Licensing

Voluntary licensing rests on consent. The patent owner and licensee may generally fix the royalty, territory, duration, exclusivity, field of use, performance obligations, confidentiality duties, quality standards, and termination events, but contractual freedom is limited by the Intellectual Property Code's technology-transfer policy and by competition principles.

A voluntary patent license should be distinguished from an assignment. In an assignment, the assignee acquires ownership or a proprietary share in the patent. In a license, the patent owner retains title, and the licensee merely receives permission to exploit the invention within the agreed limits.

Unless the license provides otherwise, the licensor is not presumed to have given up the right to exploit the invention or to grant additional licenses. Exclusivity must therefore be clear, because it restricts the patent owner's ordinary freedom to use and license the patented technology.

Unless the license limits the grant, the licensee is generally authorized to exploit the patented invention in the Philippines during the life of the patent. Territorial, field-of-use, product-line, customer, volume, and export limitations must be read with the statutory rules against prohibited clauses and unreasonable restraints.

A licensee does not acquire a right to sublicense merely because it has received a license. Sublicensing, assignment of the license, and transfer of licensed operations should be expressly authorized, especially where technical supervision, product quality, or regulatory compliance is material to the grant.

Technology Transfer Controls

The law on voluntary licensing prevents the patent owner from using the patent as a vehicle for oppressive technology transfer. The concern is not licensing itself, but clauses that extend monopoly power, suppress local adaptation, impose unnecessary dependency, or burden the licensee beyond what the transfer of technology reasonably requires.

A technology transfer arrangement that complies with the mandatory and prohibited-clause rules is enforceable without prior approval as a condition of validity. A non-complying arrangement is unenforceable unless it is approved and registered as an exceptional case by the proper office of the Intellectual Property Office after evaluation of its economic and technological benefits.

Royalty and technology-transfer payment disputes may fall within the special administrative competence of the Intellectual Property Office. This reflects the policy that royalties should correspond to the value of the technology actually transferred and should not become a device for perpetuating control after the legal or economic basis for payment has disappeared.

Prohibited Clauses in Voluntary Licenses

Prohibited clauses are stipulations that unduly restrain trade, restrict technological development, or permit abuse of the patent owner's bargaining position. They are treated by their effect, not by their drafting label.

• A clause allowing the licensor to fix sale or resale prices is prohibited because it converts the patent license into price control over the licensee's market.
• A clause restricting the licensee's production volume or production structure is prohibited when it unnecessarily prevents efficient local working of the technology.
• A clause barring the licensee from using competing technologies is prohibited in a non-exclusive license because the licensor has not given market exclusivity that could justify such restraint.
• A tie-in clause requiring the licensee to buy capital goods, raw materials, intermediate products, supplies, or other technologies from the licensor or a designated source is prohibited when it is not justified by the licensed technology itself.
• A clause requiring permanent employment of personnel chosen by the licensor is prohibited because it interferes with the licensee's business autonomy beyond technical assistance.
• A clause reserving to the licensor the right to purchase all or part of the licensee's production is prohibited when it deprives the licensee of independent commercial disposition of its output.
• A clause requiring the licensee to sell exclusively through the licensor or persons designated by the licensor is prohibited when it creates unnecessary market dependence.
• A clause restricting exports is prohibited unless the restriction protects a legitimate interest of the licensor, such as existing exclusive manufacturing or distribution rights in another territory.
• A clause restricting use of the technology after expiration of the arrangement is prohibited, except where continued quality control is legitimately required for associated rights or confidential know-how.
• A clause requiring payment for patents or other intellectual property rights after expiration, termination, or invalidation is prohibited, except as to amounts that accrued while enforceable rights or contractual benefits still existed.
• A no-contest clause preventing the licensee from challenging the validity of the patent is prohibited because invalid patents should not be insulated from legal scrutiny by private contract.
• A clause restricting research and development is prohibited because licensing should diffuse technology, not freeze the licensee's capacity to improve it.
• A clause preventing adaptation of the technology to local conditions or introduction of innovations is prohibited when the adaptation does not impair product quality or the legitimate interests protected by the license.
• A clause exempting the licensor from liability for non-fulfillment of its responsibilities, or from liability arising from third-party suits caused by the licensed technology, is prohibited when it unfairly shifts the legal risk of the licensor's own undertaking.

The list is functional. A clause with an effect equivalent to a prohibited restraint may be invalid even if it avoids the exact statutory words.

Mandatory Provisions in Voluntary Licenses

Mandatory provisions ensure that technology transfer remains legally accountable in the Philippines and that the licensee receives a continuing, usable benefit from the bargain.

• The agreement must be governed by Philippine law, because the statutory policy on technology transfer cannot be displaced by a foreign governing law clause.
• Litigation must be brought in the proper Philippine venue connected with the licensee, so that the licensee is not forced to litigate ordinary disputes in an oppressive forum.
• The licensee must have continued access to improvements in techniques and processes related to the licensed technology during the period agreed by law or contract.
• If the licensed technology becomes part of the public domain in whole or in part, the royalties must be reduced proportionately, because the licensor can no longer charge monopoly value for what the public may freely use.
• Arbitration clauses must use recognized rules, and the venue must be the Philippines or a neutral country, preserving fairness while allowing commercial dispute resolution.
• Philippine taxes on payments relating to the technology transfer are borne by the licensor, reflecting the statutory allocation of fiscal burden in such arrangements.

These mandatory terms matter most in foreign-sourced patent licenses, but they also express a domestic policy: a license should transfer usable technology on fair terms and should not merely collect royalties while disabling local development.

Royalties and Duration

Royalties may be fixed, running, milestone-based, output-based, sales-based, or a combination of these forms. They should correspond to the value of the patent rights, know-how, assistance, and other licensed benefits actually supplied.

A running royalty tied to the patent monopoly ordinarily loses its basis when the patent expires, is finally invalidated, or is no longer enforceable. However, amounts that accrued while the license was effective remain collectible, and separate compensation may be validly allocated to confidential know-how, technical services, or other non-patent benefits if these have independent value.

Minimum royalties and performance milestones are valid commercial devices when they encourage working of the invention, but they may become suspect if they operate as penalties for lawful termination, prevent challenge to invalid rights, or compel payment for technology already in the public domain.

Compulsory Licensing

A compulsory license is a non-voluntary authorization issued by law through the Intellectual Property Office allowing a qualified person to exploit a patented invention without the patent owner's consent. It is not forfeiture of the patent; ownership remains with the patentee, but exclusivity is limited for a legally sufficient reason and subject to remuneration.

The applicant must be capable of exploiting the invention. The remedy is not granted to create a paper license, but to secure actual working, supply, public access, correction of abuse, or use of a dependent technological advance.

As a general rule, the applicant must first attempt to obtain a voluntary license from the patent owner on reasonable commercial terms and must fail to obtain one within a reasonable time. This negotiation requirement may be dispensed with in cases such as national emergency, circumstances of extreme urgency, public non-commercial use, or anti-competitive conduct, but the patent owner must still be notified as the law requires.

Grounds for Compulsory License

For failure to work, the law observes a waiting period measured from filing or grant of the patent, whichever statutory period expires later. The ground is aimed at unjustified non-working, not at punishing every business delay, and the patent owner may show satisfactory reasons for the absence of commercial working.

For drugs and medicines, the Cheaper Medicines amendments are especially important. Importation of the patented article may constitute working of the patent, and special public-health rules facilitate access to affordable medicines while preserving remuneration for legitimate patent rights.

Terms of a Compulsory License

A compulsory license is limited by the purpose for which it is granted. The license should not exceed what is necessary to meet the emergency, supply the public need, correct the anti-competitive act, enable the dependent invention, or remedy non-working.

• It is non-exclusive, so the patentee may continue exploiting the invention and other licenses may be granted when legally proper.
• It is generally non-assignable except with the enterprise or part of the enterprise enjoying the license, because the authorization is tied to the licensee's capability and purpose.
• It is predominantly for the supply of the Philippine market, subject to special rules for medicines and treaty-based public-health mechanisms.
• It requires adequate remuneration to the patent owner, taking into account the economic value of the authorization and any need to correct anti-competitive conduct.
• For drugs and medicines, statutory policy limits royalties in compulsory licensing so that compensation does not defeat public access to affordable medicine.
• It may be amended or terminated when the circumstances that justified it cease and are unlikely to recur, subject to protection of the licensee's legitimate interests.

The licensee under a compulsory license must comply strictly with the terms of the grant. Unauthorized expansion of scope, non-payment of remuneration, assignment without authority, or failure to work the invention may justify amendment, cancellation, or infringement consequences.

Dependent Patents

A dependent patent exists when a later patented invention cannot be worked without infringing an earlier patent. The later patent may be valid and inventive, but its commercial use is blocked by the prior exclusive right.

A compulsory license over the earlier patent may be granted only if the later invention involves an important technical advance of considerable economic significance in relation to the earlier invention. Mere convenience, minor variation, or desire to enter the market is insufficient.

When a compulsory license is granted for a dependent patent, the owner of the earlier patent is entitled to a cross-license on reasonable terms to use the later invention. This balances the equities: the later inventor gains access to the blocking patent, while the earlier patentee gains access to the substantial improvement.

The compulsory license for a dependent patent is ordinarily transferred only with the later patent or the relevant enterprise. This prevents the license from becoming a freely tradable market asset detached from the technological relationship that justified it.

Semiconductor Technology

Compulsory licensing of semiconductor technology is narrower than ordinary patent compulsory licensing. It is generally confined to public non-commercial use or to remedying an anti-competitive practice found through proper proceedings.

This stricter treatment reflects the sensitivity of semiconductor innovation and layout-related technology, while still preserving the State's ability to intervene for public purposes or competition policy.

Government Use and Public Health Measures

Government use is closely related to compulsory licensing. The Government, or a third person authorized by it, may use a patented invention without the patent owner's agreement when the law allows public use, especially for public interest needs or to address anti-competitive exploitation.

Government use does not erase the patent. The patent owner remains entitled to notice and adequate remuneration, but the public purpose may remove the need for ordinary prior bargaining.

For patented drugs and medicines, public-health licensing rules must be read with the policy of affordable access. Special compulsory licensing mechanisms may be used to obtain or supply medicines under conditions that control quantity, destination, labeling, notification, and diversion, so that the mechanism serves health needs rather than ordinary commercial arbitrage.

Effects of Invalidity, Expiration, and Termination

Expiration of the patent ends the statutory right to exclude, and the invention falls into the public domain unless another valid right protects some separate subject matter. A license cannot validly extend patent exclusivity beyond the patent term by requiring payment solely for use of the expired patent.

Invalidation of the patent removes the legal foundation for patent-based exclusivity. Contractual consequences depend on accrued obligations, severable know-how or services, restitution principles, and the parties' lawful stipulations, but a clause forbidding validity challenges is not enforceable as a technology-transfer restraint.

Termination of the license ends the licensee's authority for future acts within the terminated scope. Continued manufacture, sale, importation, or use after termination may constitute infringement if the patent remains valid and enforceable, aside from contractual liability.

Post-termination obligations may validly protect confidential information, return of technical materials, audit of accrued royalties, inventory disposition, quality control for marked goods, and settlement of pending orders. They become invalid when they restrain lawful use of public-domain technology or compel royalty payments without a surviving legal or contractual basis.

Remedies and Enforcement

Disputes under a patent license may involve both contract and patent law. Non-payment of royalties, breach of confidentiality, failure to meet performance obligations, or violation of audit duties is ordinarily contractual; unlicensed exploitation of the patented invention is infringement if it falls within the patent claims and no defense applies.

The patent owner may sue to protect the patent from unauthorized acts. An exclusive licensee may have enforcement rights depending on the terms of the license and the interest granted, while a non-exclusive licensee ordinarily enforces its rights through contract unless the law or agreement gives a sufficient legal interest in the patent.

Administrative, civil, and contractual remedies may overlap. The proper characterization matters because a royalty dispute, a request for compulsory licensing, an infringement suit, and a challenge to an oppressive technology-transfer clause may proceed under different procedures and before different tribunals.